Head to head
Zealthy vs Measured
Both are real, operating US telehealth companies. What separates them is what they supply, what they charge for it, and what regulators have published about each — all of it below, linked to the primary documents.
- Zealthy
- Both
$135/mo - Measured
- Both
$49/mo - Zealthy on file
- 3
- Measured on file
- 1
Side by side
What each one publishes about itself
Every figure here is the provider’s own advertised number, not an estimate. A dash means the company does not publish it.
| Zealthy | Measured | |
|---|---|---|
| Supplies | Compounded and branded | Compounded and branded |
| Advertised from | $135/mo | $49/mo |
| First month | $49 | — |
| Medication in the price | Billed separately | Billed separately |
| Insurance | Both | Both |
| Intake | Async | Async |
| On the record | 3 actions | 1 action |
The difference that actually matters
Supplies both compounded medication and FDA-approved branded drugs, usually at very different prices. Check which one a quoted price refers to.
What is on Zealthy’s record
2026-04
DOJ/FTC filed an amended complaint seeking an immediate asset freeze and receivership against Zealthy and CEO Kyle Robertson, alleging foreign call-centre contractors and unlicensed non-clinicians ordering prescriptions, doctors' names and NPIs used without their knowledge, unauthorised card charges while cancellation attempts were blocked, and misuse of patients' health information for social media marketing; Zealthy also lost its LegitScript certification in 2025.
2024-04
Zealthy CEO Kyle Robertson is the founding CEO of Cerebral, which settled FTC/DOJ charges over data sharing and deceptive cancellation practices.
2024-05
The United States, on referral from the FTC, sued Cerebral, Inc., Zealthy, Inc., Gronk, Inc. and chief executive Kyle Robertson in the Southern District of Florida (No. 1:24-cv-21376); the first amended complaint of 31 May 2024 alleges deceptive cancellation practices and mishandling of consumers' health data. Allegations unproven.
What is on Measured’s record
2026-02
FDA warning letter to Better Health Labs, Inc. dba Measured alleging it misbranded compounded semaglutide and tirzepatide by displaying "Measured" on the pictured labels, suggesting Measured was the compounder when it was not, and by advertising products with "the same active ingredients found in Wegovy, Ozempic, Zepbound, and Mounjaro", which the agency said implies FDA approval the compounded products do not have.
Go direct
Both companies, and what we earn from each
We do not recommend one over the other. Where a link pays us, it says so here and on the provider’s own page.
Zealthy
Compounded and branded, from $135 a month. 3 actions on record, each linked on its page. The link below earns us nothing.
Measured
Compounded and branded, from $49 a month. 1 action on record, each linked on its page. The link below earns us nothing.
Straight answers
Zealthy vs Measured, in short
- Is Zealthy or Measured cheaper?
- Measured advertises the lower starting price — $49 a month against $135, roughly 2.8× the difference. Whether that is the cheaper purchase depends on what each figure covers: Zealthy bills medication separately, and Measured bills it separately.
- What is the difference between Zealthy and Measured?
- Both supply the same category — both compounded and FDA-approved medication — so the differences are price, how the consultation works, and what each one has on its regulatory record.
- Which one has more regulatory actions on record?
- Zealthy, with 3 sourced actions against 1 action for Measured. Every one is linked to its primary document on the provider's own page. A larger file is not automatically a worse company — read what the documents actually say.
Other comparisons: Mochi Health vs Zealthy · Eden vs Zealthy · Pallas Health vs Zealthy